SISSY HINOJOS: Open Payments
NPI 1972843795 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,108 in 123 payments from 45 companies in 2025. Trend: 2023 $5,246 · 2024 $3,950 · 2025 $4,108
Food & beverage: $4,108
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $448 |
| AstraZeneca Pharmaceuticals LP | 9 | $360 |
| Genmab U.S., Inc. | 4 | $257 |
| Pharmacosmos Therapeutics Inc. | 6 | $218 |
| GlaxoSmithKline, LLC. | 7 | $209 |
| Incyte Corporation | 4 | $177 |
| Stemline Therapeutics Inc. | 4 | $156 |
| Lilly USA, LLC | 4 | $151 |
| Exelixis Inc. | 3 | $145 |
| Myriad Genetic Laboratories, Inc. | 2 | $140 |
Products named: RYBREVANT, JEMPERLI, DARZALEX, MONOFERRIC, MONJUVI, Orserdu, VERZENIO, CABOMETYX.
Industry payments across TX — which companies pay providers there.
